17 July, 2013 - British Heart Foundation Awards ZOLL a Tender for AEDs for Another Three-Year Term
MEDIA CONTACT: |
Diane Egan |
Jill Garratt |
BRITISH HEART FOUNDATION AWARDS ZOLL A TENDER FOR AEDS FOR ANOTHER THREE-YEAR TERM
17 July, 2013—CHELMSFORD, MASS.—ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, announced today that it has been selected as a nominated supplier by the British Heart Foundation (BHF) for the ZOLL AED Plus® through 2016.
ZOLL has been working in partnership with the BHF since 2010 to supply the AED Plus through their part-funding program, which recommends the device to communities and organizations requesting funding for AEDs and offers it at a discounted rate. ZOLL has supplied numerous AEDs to public places and areas of need throughout the United Kingdom in conjunction with its existing partnership with the BHF.
The tender process involves leading professionals from both the medical community and ambulance service who scrutinize all aspects vital to the delivery of BHF’s community resuscitation work. The clinical aspects of the devices, account management, compliance with resuscitation guidelines, and compatibility with the ambulance services are all taken into account.
Sarah Forsey, Grants and Awards Manager at the BHF, said, “Less than 10% of the 30,000 people that suffer a cardiac arrest outside of hospital live long enough to leave hospital alive. But many of these lives could be saved if more defibrillators were available in public places. Since 1996 the BHF has placed more than 9,500 defibrillators around the UK, many of which have been used in an emergency. We are therefore delighted to be continuing our relationship with ZOLL as we work to make more AEDs readily available in UK communities.”
“Over the last three years, we have seen consistent growth in the AED market in the United Kingdom with communities and businesses beginning to realize the importance of these life-saving devices. This market will continue to grow and we are looking forward to the next three years working in partnership with the British Heart Foundation in helping to save lives from sudden cardiac arrest,” said Jonathan A. Rennert, President of ZOLL.
About the AED Plus
The ZOLL AED Plus is the first and only Full-Rescue AED that provides Real CPR Help® for the depth and rate of chest compressions during CPR. This feedback technology helps rescuers provide high-quality manual CPR with real-time audio and visual feedback to help them achieve the proper depth and rate of CPR chest compressions. The AED Plus guides rescuers through the complete Chain of Survival, helping all sudden cardiac arrest victims, not just those who need a shock.
About Sudden Cardiac Arrest
SCA is an abrupt disruption of the heart’s function, which causes a lack of blood flow to vital organs. SCA claims more than 1 million lives globally each year. It is the leading cause of unexpected death in the world and often strikes without warning. Survival varies widely among communities, yet overall averages around 8% in the United Kingdom.
About the British Heart Foundation
Coronary heart disease is the UK’s single biggest killer. For over 50 years we’ve pioneered research that’s transformed the lives of people living with heart and circulatory conditions. Our work has been central to the discoveries of vital treatments that are changing the fight against heart disease. But so many people still need our help. From babies born with life-threatening heart problems to the many Mums, Dads and Grandparents who survive a heart attack and endure the daily battles of heart failure. Every pound raised, minute of your time and donation to our shops will help make a difference to people’s lives. For more information, visit www.bhf.org.uk.
About ZOLL Medical Corporation
ZOLL Medical Corporation, an Asahi Kasei Group company, develops and markets medical devices and software solutions that help advance emergency care and save lives, while increasing clinical and operational efficiencies. With products for defibrillation and monitoring, circulation and CPR feedback, data management, fluid resuscitation, and therapeutic temperature management, ZOLL provides a comprehensive set of technologies that help clinicians, EMS and fire professionals, and lay rescuers treat victims needing resuscitation and critical care.
About Asahi Kasei
The Asahi Kasei Group is a diversified group of companies led by holding company Asahi Kasei Corp., with operations in the chemicals and fibers, homes and construction materials, electronics, and health care business sectors. Its health care operations include devices and systems for critical care, dialysis, therapeutic apheresis, transfusion, and manufacture of biotherapeutics, as well as pharmaceuticals, diagnostic reagents, and nutritional products. With more than 25,000 employees around the world, the Asahi Kasei Group serves customers in more than 100 countries. For more information, visit www.asahi-kasei.co.jp/asahi/en/.
Copyright © 2013 ZOLL Medical Corporation. All rights reserved. AED Plus, Real CPR Help, and ZOLL are trademarks or registered trademarks of ZOLL Medical Corporation or its subsidiaries in the United States and/or other countries. Asahi Kasei is a registered trademark of Asahi Kasei Corporation. All trademarks are the property of their respective owners.